These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24839073)

  • 1. BET 1: levosimendan in septic shock.
    Coates J; Mathieu S
    Emerg Med J; 2014 Jun; 31(6):508-10. PubMed ID: 24839073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction.
    Emerg Med J; 2013 Dec; 30(12):1060-2. PubMed ID: 24232006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan in septic shock: a case series.
    Powell BP; De Keulenaer BL
    Br J Anaesth; 2007 Sep; 99(3):447-8. PubMed ID: 17702832
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful reversal of resistent hypodynamic septic shock with levosimendan.
    Matejovic M; Krouzecky A; Radej J; Novak I
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):127-8. PubMed ID: 15676005
    [No Abstract]   [Full Text] [Related]  

  • 5. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials.
    Bhattacharjee S; Soni KD; Maitra S; Baidya DK
    J Clin Anesth; 2017 Jun; 39():67-72. PubMed ID: 28494911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan reduces mortality in patients with severe sepsis and septic shock: A meta-analysis of randomized trials.
    Zangrillo A; Putzu A; Monaco F; Oriani A; Frau G; De Luca M; Di Tomasso N; Bignami E; Lomivorotov V; Likhvantsev V; Landoni G
    J Crit Care; 2015 Oct; 30(5):908-13. PubMed ID: 26093802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levosimendan for septic shock with takotsubo cardiomyopathy].
    Schlürmann CN; Reinöhl J; Kalbhenn J
    Anaesthesist; 2016 Jan; 65(1):46-49. PubMed ID: 26620046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan in septic shock: another piece in the puzzle, but many pieces are still lacking.
    De Backer D; Taccone FS; Radermacher P
    Intensive Care Med; 2007 Mar; 33(3):403-5. PubMed ID: 17262189
    [No Abstract]   [Full Text] [Related]  

  • 9. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan in septic cardiac failure.
    Noto A; Giacomini M; Palandi A; Stabile L; Reali-Forster C; Iapichino G
    Intensive Care Med; 2005 Jan; 31(1):164-5. PubMed ID: 15580334
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of levosimendan in sepsis and septic shock.
    Pinto BB; Rehberg S; Ertmer C; Westphal M
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):168-77. PubMed ID: 18443483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan in early sepsis: when good ideas give poor results.
    De Backer D; Bracht H
    Anesth Analg; 2009 Nov; 109(5):1367-9. PubMed ID: 19843771
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases.
    Papoff P; Caresta E; Versacci P; Pinto R; Moretti C; Midulla F
    Pediatr Emerg Care; 2012 Oct; 28(10):1062-5. PubMed ID: 23034494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan for treatment of septic shock: homeotherapy or inadequate therapy?
    Yang JJ; Ji MH; Sun J; Peng YG
    Acta Anaesthesiol Scand; 2011 Oct; 55(9):1147; author reply 1147-8. PubMed ID: 22092214
    [No Abstract]   [Full Text] [Related]  

  • 15. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock.
    García-Septien J; Lorente JA; Delgado MA; de Paula M; Nin N; Moscoso A; Sánchez-Ferrer A; Perez-Vizcaino F; Esteban A
    Shock; 2010 Sep; 34(3):275-80. PubMed ID: 19997054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial depression associated with pneumococcal septic shock reversed by levosimendan.
    Ramaswamykanive H; Bihari D; Solano TR
    Anaesth Intensive Care; 2007 Jun; 35(3):409-13. PubMed ID: 17591138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paediatric use of levosimendan in septic shock].
    Monteverde E; Neira P; Farías J
    An Pediatr (Barc); 2008 May; 68(5):529-30. PubMed ID: 18448005
    [No Abstract]   [Full Text] [Related]  

  • 18. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 19. Levosimendan: a new option in acute septic cardiac failure?
    Powell BP; De Keulenaer B
    Emerg Med Australas; 2007 Apr; 19(2):177; author reply 177-8. PubMed ID: 17448109
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials.
    Chang W; Xie JF; Xu JY; Yang Y
    BMJ Open; 2018 Mar; 8(3):e019338. PubMed ID: 29602841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.